跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
诺和锐 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Insulin Aspart Injection
Approved
生物制品
Insulin Aspart Injection
Novo Nordisk A/S
🇨🇳 National Medical Products Administration
Approval Date
Nov 15, 2019
Approval ID
7MazXbsIQPC
Company
Novo Nordisk A/S
Type
生物制品
Approval Details
Approval Id
7MazXbsIQPC
Approval Number
S20140111
Generic Name
门冬胰岛素注射液
Generic Name En
Insulin Aspart Injection
Trade Name
诺和锐
Drug Type
生物制品
Dosage Form
注射剂
Strength
3ml:300单位(笔芯)
Reg Date
2019-11-15
Expired Date
2024-11-14
Company Name
Novo Nordisk A/S
Company Address
Novo Alle, DK-2880 Bagsvaerd, Denmark
Production Company Name
Novo Nordisk A/S
Production Company Address
Novo Alle,DK-2880 Bagsvaerd
Company Detail Path
/organization/novo-nordisk-a-s
Production Company Detail Path
/organization/novo-nordisk-a-s
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 15, 2019
Approval ID
7MazXbsIQPC
Type
生物制品
Back to NMPA Approvals